The Saliva Glucose Biosensor and The iQ Group Global are in the headlines again, this time featuring on the homepage of popular medical technologies news site Medgadget. Read the article here.

The iQ Group Global appeared in Diagnostics World News today, a leading publication for emerging technologies in diagnostics. The article is a feature on the Saliva Glucose Biosensor, the world’s first saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood. To read the article in full visit the website

Dr George Syrmalis, Group CEO and Chairman of The iQ Group Global, is featured in The Australian Financial Review today. In the interview Dr Syrmalis discusses the evolution of biotech in China, outlines The Group’s plans to enter the Chinese market with the ground-breaking biosensor platform technology, and details the strategy behind The Group’s proposed […]

Dr George Syrmalis, Group CEO of The iQ Group Global, is featured in the November edition of The CEO Magazine. In his interview ‘The Power of Practical Thinking’, Dr Syrmalis discusses his approach to leadership, outlines his vision for The Group’s future, and highlights the necessity for pragmatism in the biopharmaceutical industry. The article also […]

In yesterday’s market announcement, iQnovate Ltd (IQN) intends to redomicile in the US, in preparation for an intended listing on Nasdaq. The redomicile is being carried out via a scheme of arrangement between IQN and The iQ Group Global Inc (TIGG). “After seven years of significant growth in Australia, IQN has acquired, developed and de-risked […]

iQnovate Ltd (NSX:IQN) The executive management of iQnovate Ltd, on behalf of its subsidiary company Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce it has been granted a key patent for its biosensor platform in the People’s Republic of China. This will enable LSBD to enjoy patent protection in China until the […]

The executive management of iQnovate Ltd on behalf of its subsidiary company, Life Science Biosensor Diagnostics Pty Ltd, is pleased to provide the following update on the development program for the Saliva Glucose Biosensor and its broader Biosensor Platform – BioSensX, with the initiation of three new diagnostic test portfolios. Saliva Glucose Biosensor The Saliva […]

Dr George Syrmalis, CEO and founder of The iQ Group Global was recently interviewed by Alan Kohler as part of the CEO Interview series on the investor subscription website, The Constant Investor. Dr Syrmalis discusses what people should consider when investing in biotech and the interview, in Alan’s own words, is ‘fascinating’ and ‘really worth […]